7-21892438-T-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001277115.2(DNAH11):c.12521T>G(p.Leu4174Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000541 in 1,610,726 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0030   (  1   hom.,  cov: 32) 
 Exomes 𝑓:  0.00028   (  2   hom.  ) 
Consequence
 DNAH11
NM_001277115.2 missense
NM_001277115.2 missense
Scores
 1
 7
 8
Clinical Significance
Conservation
 PhyloP100:  5.51  
Publications
0 publications found 
Genes affected
 DNAH11  (HGNC:2942):  (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013] 
DNAH11 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
 - primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.003577292). 
BP6
Variant 7-21892438-T-G is Benign according to our data. Variant chr7-21892438-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00304 (463/152300) while in subpopulation AFR AF = 0.0105 (438/41568). AF 95% confidence interval is 0.00972. There are 1 homozygotes in GnomAd4. There are 219 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00303  AC: 461AN: 152182Hom.:  1  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
461
AN: 
152182
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000763  AC: 189AN: 247552 AF XY:  0.000604   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
189
AN: 
247552
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000280  AC: 409AN: 1458426Hom.:  2  Cov.: 33 AF XY:  0.000248  AC XY: 180AN XY: 724812 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
409
AN: 
1458426
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
180
AN XY: 
724812
show subpopulations 
African (AFR) 
 AF: 
AC: 
344
AN: 
33436
American (AMR) 
 AF: 
AC: 
26
AN: 
44594
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26002
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39624
South Asian (SAS) 
 AF: 
AC: 
5
AN: 
86046
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53332
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5748
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
1109420
Other (OTH) 
 AF: 
AC: 
32
AN: 
60224
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.493 
Heterozygous variant carriers
 0 
 23 
 46 
 69 
 92 
 115 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00304  AC: 463AN: 152300Hom.:  1  Cov.: 32 AF XY:  0.00294  AC XY: 219AN XY: 74470 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
463
AN: 
152300
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
219
AN XY: 
74470
show subpopulations 
African (AFR) 
 AF: 
AC: 
438
AN: 
41568
American (AMR) 
 AF: 
AC: 
18
AN: 
15296
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10622
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68024
Other (OTH) 
 AF: 
AC: 
5
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 23 
 46 
 68 
 91 
 114 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ESP6500AA 
 AF: 
AC: 
34
ESP6500EA 
 AF: 
AC: 
1
ExAC 
 AF: 
AC: 
114
Asia WGS 
 AF: 
AC: 
2
AN: 
3478
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 7    Benign:1 
Jan 31, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia    Benign:1 
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
.;.;T 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Uncertain 
D;D;D 
 MetaRNN 
 Benign 
T;T;T 
 MetaSVM 
 Benign 
T 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Pathogenic 
.;D;. 
 REVEL 
 Benign 
 Sift 
 Uncertain 
.;D;. 
 Vest4 
 MVP 
 ClinPred 
T 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.